Phase I trial of ITV-1 in patients with HIV infections or AIDS.
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2012
Price : $35 *
At a glance
- Drugs ITV 1 (Primary)
- Indications Acquired immunodeficiency syndrome; HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Immunotech Laboratories
- 12 Sep 2012 New trial record
- 05 Sep 2012 Endpoint 'Viral load' has been met.